GENETICS, published by the Genetics Society of America, stands as a preeminent journal in the field of genetics, with a keen focus on advancing the understanding of genetic principles and their implications across various biological systems. Since its inception in 1945, the journal has played a pivotal role in disseminating groundbreaking research, maintaining a Q1 ranking in the genetics category as of 2023, positioning it among the top tier of academic publications. While access to the journal is not open, it continues to attract a global readership of researchers, professionals, and students eager to engage with high-quality, peer-reviewed articles that span both classical and contemporary genetics. With its publication history covering critical decades from 1945 to 2024, GENETICS is not just a repository of scientific knowledge but a vibrant forum for the exchange of ideas that drive the field forward. The journal’s commitment to excellence is demonstrated by its strategic coverage of pertinent topics, assuring its relevance for future generations of scholars.

Molecular Syndromology is a premier journal focused on the intricate connections between molecular genetics and syndromology, fostering discussions that advance our understanding of genetic disorders and their clinical implications. Published by KARGER, a distinguished name in medical and scientific publishing, this journal serves as a valuable platform for researchers, clinicians, and students in the field of genetics. With its ISSN 1661-8769 and E-ISSN 1661-8777, the journal has gained recognition in its category, currently positioned in the Q4 quartile for both genetic and clinical genetics disciplines according to the latest metrics. Despite being indexed lower in Scopus rankings, it addresses crucial gaps in research and offers open access options that enhance visibility and dissemination of knowledge. As it continues to converge from 2010 to 2024, Molecular Syndromology aims to bridge the gap between molecular research and its clinical applications, making a significant impact in the evolving landscape of genetic medicine.

Application of Clinical Genetics is a premier open-access journal published by Dove Medical Press Ltd., dedicated to advancing the field of clinical genetics since its inception in 2008. Based in New Zealand, this journal has established itself as a significant resource for researchers, clinicians, and students alike, contributing to the body of knowledge in both genetic medicine and clinical applications. With an impact factor reflecting its contributions to the field, the journal holds positions in the Q2 and Q3 quartiles of the 2023 Genetics categories, showcasing its relevance and scientific merit. Furthermore, it ranks #43 out of 99 in Clinical Genetics and #153 out of 347 in Biochemistry, Genetics, and Molecular Biology, indicating robust performance amongst its peers. The journal’s broad scope, encompassing various aspects of clinical genetics, ensures that it remains at the forefront of critical discussions, innovative research, and applications essential for the progression of personalized medicine. Researchers and professionals are encouraged to explore its openly accessible content that fosters collaboration and the sharing of knowledge in this dynamic and rapidly evolving field.

AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS is a premier peer-reviewed journal published by Wiley, focusing on the intricate and evolving field of medical genetics. With its ISSN 1552-4868 and E-ISSN 1552-4876, the journal has established itself as a significant resource for researchers, professionals, and students alike, addressing cutting-edge developments in genetic research and clinical practice. Ranked in the top quartile (Q2) in both Genetics and clinical Genetics categories for 2023, it maintains an impressive Scopus ranking, positioning it within the 75th and 71st percentiles for Medicine and Genetics respectively. The journal encourages open access to its content, promoting wider dissemination of knowledge and fostering collaboration among medical genetics experts. From its inaugural issues in 1980 to its ongoing publications, the journal aims to bridge the gap between genetics research and its clinical applications, providing insights that reflect the latest advancements in the field. As it continues to serve the global medical community, the AMERICAN JOURNAL OF MEDICAL GENETICS PART C remains a vital source for those seeking to understand the complexities of genetic disorders and their implications for health and disease.

The American Journal of Human Genetics, published by Cell Press, stands at the forefront of the genetics field, serving as an invaluable resource for researchers, clinicians, and students alike. With ISSN 0002-9297 and E-ISSN 1537-6605, this esteemed journal has been a cornerstone of genetic research since its inception in 1950 and continues to shape the landscape of human genetics as it evolves through 2024. Recognized for its exceptional quality, it holds a prestigious Q1 ranking in both genetics and clinical genetics, highlighting its significance and impact in the scientific community. With Scopus rankings placing it 5th out of 99 in clinical genetics and 20th out of 347 in biochemistry, genetics, and molecular biology, the journal attracts cutting-edge research and groundbreaking discoveries. While the journal maintains a subscription-only model for access, its contributions are critical in advancing our understanding of human genetics, making it a must-read for those dedicated to pushing the boundaries of knowledge in this dynamic field.

Genetic Testing and Molecular Biomarkers, an esteemed journal published by MARY ANN LIEBERT, INC, serves as a pivotal platform for advancing the field of genetic research and its applications in medicine. Focused on the innovative intersections of genetics and biomarker discovery, this journal has consistently contributed meaningful insights since its inception in 2009, with its scope evolving through 2024. With an ISSN of 1945-0265 and an E-ISSN of 1945-0257, it offers both traditional and open access options to cater to a broad audience of researchers, professionals, and students. Despite its current classification in the Q4 and Q3 quartiles for Genetics (clinical) and Medicine (miscellaneous) respectively, the journal remains committed to publishing high-quality, peer-reviewed articles that push the boundaries of knowledge in the field. As the landscape of genomic medicine continues to expand, Genetic Testing and Molecular Biomarkers is positioned as a crucial resource for disseminating cutting-edge discoveries and fostering interdisciplinary collaboration.

CLINICAL GENETICS is a premier journal in the field of genetics, published by Wiley, and is renowned for advancing the understanding of genetic disorders and their clinical applications. With a notable impact factor and ranking in the top quartile (Q1) in both general genetics and clinical genetics as of 2023, this journal is instrumental for researchers, professionals, and students seeking to explore groundbreaking studies and developments in genetics. Since its inception in 1970, CLINICAL GENETICS has continued to publish high-quality, rigorously peer-reviewed research that pushes the boundaries of knowledge in clinical genetics. The journal maintains a strong reputation in its field, currently holding significant positions in Scopus rankings, including 30th out of 99 in clinical genetics, underscoring its relevance and impact in the field. For those interested, the journal's website provides comprehensive access options for current and archived research, making it an essential resource for anyone involved in genetic research and its clinical application.

The Journal of Community Genetics, published by SPRINGER HEIDELBERG, is an influential Open Access journal dedicated to advancing the field of genetics in community settings. Since its inception in 2000, this journal has provided a platform for comprehensive interdisciplinary research that encompasses the critical intersections of genetics, public health, and epidemiology. Situated in Germany, the journal has positioned itself prominently within the academic community, evidenced by its 2023 impact rankings, which place it in the Q3 category for both Epidemiology and Genetics (clinical) and Q2 for Public Health, Environmental and Occupational Health. With an expanding scope that includes innovative research from 2010 to 2024, the journal aims to foster dialogue among researchers, healthcare professionals, and policymakers, ultimately driving advancements in community health genetics. The open access model ensures that this vital information is readily available to a global audience, reinforcing its commitment to public health improvement and genetic literacy.

ANNALS OF HUMAN GENETICS is a distinguished peer-reviewed journal extensively covering the field of genetics, published by Wiley. Established in 1954 and extending its influence into 2024, this journal features comprehensive research articles, reviews, and case studies aimed at advancing our understanding of human genetic conditions and their implications on health. With its ISSN number 0003-4800 and E-ISSN 1469-1809, the journal has carved a prominent niche within the academic community, currently ranking in the third quartile in both genetic and clinical genetics categories (Q3, 2023). Its Scopus rankings reflect its credibility, placing it #54 out of 99 in clinical genetics. Though it is not open access, it remains an essential resource for researchers and practitioners seeking to explore the latest findings and methodologies in genetics, serving as a critical platform for knowledge dissemination and dialogue within the scientific community. As we delve deeper into the complexities of our genetic makeup, the ANNALS OF HUMAN GENETICS continues to play a vital role in fostering innovation and collaboration in this ever-evolving field.

GENETICS IN MEDICINE, published by Elsevier Science Inc, stands as a premier journal in the realms of clinical genetics and medicine. With an impressive impact factor and ranked #3 out of 99 in the category of Genetics (clinical), alongside a 97th percentile ranking in the Scopus database, this journal is recognized for its outstanding contribution to the field. Established in 1998, it aims to disseminate innovative research and clinical advancements bridging genetics and medical practice, making it essential reading for researchers, healthcare professionals, and students alike. Although not an open-access journal, GENETICS IN MEDICINE provides valuable insights into genetics that drive the future of personalized medicine and patient care. With a commitment to excellence, the journal continuously explores the evolving landscape of genetic research to foster the understanding and application of genetic principles in medical contexts.